Big Pharma manages symptoms. This startup resolves the root cause.

For over 125 years, inflammation care has relied on symptom suppression.

Aspirin was groundbreaking in its time — but in a world plagued by chronic inflammation — we all need something better.

​Sen-Jam​ is pioneering the first true leapfrog advance in inflammatory care.

Q: What do cancer, heart disease, and rheumatoid arthritis have in common? A: Inflammation drives them all.

Inflammation is a silent epidemic, at the core of countless chronic diseases. Yet today’s treatments only mask symptoms or worse suppress the body’s immune system, leaving the root cause untouched.

Sen-Jam changes that.

With its revolutionary ​PAIR (Pleiotropic Anti-Inflammatory Remedies)​ technology, Sen-Jam comprehensively targets inflammation at its source, delivering the most transformative advance since aspirin was invented.

This isn’t just an improvement—it’s a paradigm shift.

How does Sen-Jam work?

Most therapies target single inflammatory pathways — like fighting a wildfire with a squirt gun 🔥🔫

PAIR acts like a maestro, coordinating multiple inflammatory pathways for additive, powerful results.

In a Phase 2 clinical trial for SJP-002C, PAIR demonstrated:

• Strong efficacy in treating respiratory inflammation

• An exceptional safety profile, addressing both symptoms and roo causes.

“Our approach is so simple and powerful, it’s like discovering the next aspirin — an essential solution that changes everything.

Why invest in Sen-Jam?

• Massive TAM: Inflammation underlies a wide range of diseases, driving a $125 billion market projected by 2030.

• Unprecedented Innovation: 60 patents strong, Sen-Jam’s groundbreaking platform is positioned to disrupt the $1.48T pharma industry.

• Past successful exits: Backed by a team of scientific experts and entrepreneurial veterans with a proven track record.

“This is the inflection point. Science, timing, and market demand have aligned for the biggest advance in 125 years.

Perks of investing

• Invest any amount and get ​Fractional Royalty Rights​ as annual dividends

• Bonus Incentives for Larger Investments:

  • $25k+: 10% bonus in stock

  • $50k+: 12% bonus in stock

  • $100k+: 14% bonus in stock

Note: these favorable terms sunset February 15th

Be part of the next breakthrough in healthcare.

Express interest

Click the button below to:

1. Gain access to exclusive updates

2. Take your place in shaping the future of healthcare

3. Invest in the most transformative advance in over a century

The future of inflammation care starts now.

Transform health. Transform lives. Transform your portfolio.

To learn more about Sen-Jam without giving permission to email, ​click here​.

📰 Market Headlines

The market trended downwards as the Fed decided to keep rates unchanged at 4.25%-4.5%.

• The Nasdaq and the S&P 500 dropped 0.5% as the Dow dropped 0.3%.

• The Fed removed language about inflation progress from its statement, signaling rates could stay higher for longer.

President Trump settled his lawsuit with Meta for $25 million, with $22 million earmarked for his presidential library.

Nvidia shares tumbled over 4% following reports of potential additional curbs on its chip sales to China.

President Trump ordered the expansion of the detention center at Guantanamo Bay to house 30,000 undocumented migrants.

🧠 Make yourself heard

Quiz time…don’t cheat.

 📊 Ideas, trends, and analysis

• The US commercial waste bins market is projected to reach $258 million by 2029.

😱 Fear and Greed Index

📊 Winners and losers

Earnings, upgrades, and acquisitions

• ASML doubled expected orders; shares surged 4.3%.

• General Dynamics Gulfstream sales missed estimates; shares tumbled 4%.

• IBM reported its biggest software revenue jump in five years; shares soared 10%.

• Meta warned of slowing growth and higher AI infrastructure costs; shares wavered before settling up 1%.

• Microsoft Intelligent Cloud missed expectations under DeepSeek concerns; shares dropped 4%.

• Tesla posted its first annual delivery decline, as full-year adjusted net income dropped 23%; shares fell 3%.

Market movers

• Honda boosted investment in three Ohio auto plants by $300 million.

• Instagram rolled out new analytics tools for creators following the US TikTok ban.

• MoviePass surveyed customers about pivoting to crypto and blockchain technology.

• Pratt & Whitney confirmed layoffs at its East Hartford location as part of cost reduction efforts.

🎤 What you said last time

📺 What to Watch Today